Key statistics
On Friday, Orchestra Biomed Holdings Inc (OBIO:NMQ) closed at 3.83, 74.09% above the 52 week low of 2.20 set on Sep 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.84 |
|---|---|
| High | 3.99 |
| Low | 3.78 |
| Bid | 3.50 |
| Offer | 4.17 |
| Previous close | 3.82 |
| Average volume | 202.50k |
|---|---|
| Shares outstanding | 56.46m |
| Free float | 39.55m |
| P/E (TTM) | -- |
| Market cap | 216.26m USD |
| EPS (TTM) | -1.82 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
- Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
- Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
- Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
- Orchestra BioMed to Host Business Update Call on November 12, 2025
- Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
- Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
- Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit
More ▼
